BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:B1962 readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of B1962\, from ClinicalTrials.gov estimates
 .
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT06838546-2377@assetmemo.bio
DTSTAMP:20261121T004542Z
DTSTART;VALUE=DATE:20270101
DTEND;VALUE=DATE:20270102
SUMMARY:B1962: Phase 2 readout est. (NCT06838546)
DESCRIPTION:B1962\, phase 2.\nStudy: A Multicenter\, Open Phase IIb Clinica
 l Study to Evaluate the Efficacy and Safety of B1962 Injection in the Trea
 tment of Advanced Colorectal Cancer\nEstimated primary completion: 1 Janua
 ry 2027. This is a ClinicalTrials.gov estimate\, not a confirmed readout d
 ate\, and it can move.\nDrug page: https://assetmemo.bio/drug/b1962#upcomi
 ng-events\nRegistry record: https://clinicaltrials.gov/study/NCT06838546
URL:https://assetmemo.bio/drug/b1962#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
